Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | BTN3A1 | O00481 | 5/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.33 |
| ▸ | MSR1 | P21757 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1834290 | 1.00 | SRC (0.48) | SRCSTAT3ACHEPTPN1TRPA1 | |
| SCHEMBL17785039 | 1.00 | SRC (0.48) | SRCSTAT3ACHEPTPN1TRPA1 | |
| SCHEMBL12500490 | 1.00 | SRC (0.48) | SRCSTAT3ACHEPTPN1TRPA1 | |
| SCHEMBL29558348 | 1.00 | SRC (0.48) | SRCSTAT3ACHEPTPN1TRPA1 | |
| SCHEMBL17785040 | 1.00 | SRC (0.48) | SRCSTAT3ACHEPTPN1TRPA1 | |
| SCHEMBL156333 | 0.84 | SRC (0.59) | SRCSTAT3ACHEPTPN1ALOX5 | |
| SCHEMBL309480 | 0.84 | SRC (0.59) | SRCSTAT3ACHEPTPN1ALOX5 | |
| SCHEMBL17627685 | 0.84 | SRC (0.59) | SRCSTAT3ACHEPTPN1ALOX5 | |
| SCHEMBL5718782 | 0.83 | SRC (0.55) | SRCSTAT3PTPN1 | |
| SCHEMBL5718784 | 0.83 | SRC (0.55) | SRCSTAT3PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220370535-A1 | ANTIVIRAL ESSENTIAL OIL COMPOSITIONS | ERDOGMUS, HÜSEYIN (TR) | 2022-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220370535-A1 | ANTIVIRAL ESSENTIAL OIL COMPOSITIONS | CYP51A1, NR1H2, CYP2R1 | SRC 774/4885STAT3 888/4885ACHE 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.